Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 1333 for:    Hematologic neoplasm

Biomarker Research for Personalized Medicine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01488591
Recruitment Status : Unknown
Verified May 2013 by Jae-Gook Shin, Inje University.
Recruitment status was:  Recruiting
First Posted : December 8, 2011
Last Update Posted : May 31, 2013
Sponsor:
Information provided by (Responsible Party):
Jae-Gook Shin, Inje University

Tracking Information
First Submitted Date December 6, 2011
First Posted Date December 8, 2011
Last Update Posted Date May 31, 2013
Study Start Date April 2009
Primary Completion Date Not Provided
Current Primary Outcome Measures Not Provided
Original Primary Outcome Measures Not Provided
Change History Complete list of historical versions of study NCT01488591 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Biomarker Research for Personalized Medicine
Official Title Biomarker Research for Personalized Medicine in Blood Cancer Patient
Brief Summary

The aim of this study :

  1. Through the study of genes of protein, transporter, translator and epigenome investigating the effect of anti-cancer treatment or the key factor of the MDR (Multidrug resistance) on the blood cancer patients who are under the anti-cancer sork treatment
  2. Giving a service of anticancer medicine therapeutic drug monitoring (TDM) and genotyping
Detailed Description Not Provided
Study Type Observational
Study Design Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Retention:   Samples With DNA
Description:
whole blood
Sampling Method Probability Sample
Study Population healthy volunteers
Condition Hematologic Neoplasms
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: December¬†7,¬†2011)
1000
Original Estimated Enrollment Same as current
Study Completion Date Not Provided
Primary Completion Date Not Provided
Eligibility Criteria

Inclusion Criteria:

  • Korean
  • Clinical diagnosis of Hematologic neoplasms
Sex/Gender
Sexes Eligible for Study: All
Ages Child, Adult, Older Adult
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Korea, Republic of
Removed Location Countries  
 
Administrative Information
NCT Number NCT01488591
Other Study ID Numbers 09-029
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Jae-Gook Shin, Inje University
Study Sponsor Inje University
Collaborators Not Provided
Investigators Not Provided
PRS Account Inje University
Verification Date May 2013